These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8397766)

  • 41. Monoclonal antibodies in the treatment of lung cancer.
    Egri G; Takáts A
    Eur J Surg Oncol; 2006 May; 32(4):385-94. PubMed ID: 16504454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant antibody fragments and immunotoxin fusions for cancer therapy.
    Brinkmann U
    In Vivo; 2000; 14(1):21-7. PubMed ID: 10757057
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxins.
    Derocq JM; Casellas P; Laurent G; Ravel S; Vidal H; Jansen F
    J Immunol; 1988 Oct; 141(8):2837-43. PubMed ID: 3262669
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel genetic immunotoxins and intracellular antibodies for cancer therapy.
    Chen SY; Marasco WA
    Semin Oncol; 1996 Feb; 23(1):148-53. PubMed ID: 8607024
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current status of antitumor therapy with monoclonal antibodies.
    Scheinberg DA; Houghton AN
    Oncology (Williston Park); 1987 May; 1(3):31-40. PubMed ID: 3079479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunotoxin therapy of malignant melanoma.
    Spitler LE
    Med Oncol Tumor Pharmacother; 1986; 3(3-4):147-52. PubMed ID: 3543527
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant antibodies in cancer therapy.
    Nayeem MS; Khan RH
    Curr Protein Pept Sci; 2006 Apr; 7(2):165-70. PubMed ID: 16611141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunotoxin: A new tool for cancer therapy.
    Allahyari H; Heidari S; Ghamgosha M; Saffarian P; Amani J
    Tumour Biol; 2017 Feb; 39(2):1010428317692226. PubMed ID: 28218037
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant immunotoxins in targeted cancer cell therapy.
    Reiter Y
    Adv Cancer Res; 2001; 81():93-124. PubMed ID: 11430597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modern immunotherapy of cancer.
    Ravikumar TS; Steele GD
    Adv Surg; 1991; 24():41-68. PubMed ID: 1996529
    [No Abstract]   [Full Text] [Related]  

  • 51. Enhancement of immunotoxin activity using chemical and biological reagents.
    Wu M
    Br J Cancer; 1997; 75(9):1347-55. PubMed ID: 9155057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunotoxins: an update.
    Thrush GR; Lark LR; Clinchy BC; Vitetta ES
    Annu Rev Immunol; 1996; 14():49-71. PubMed ID: 8717507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Magic bullets fly again.
    Ezzell C
    Sci Am; 2001 Oct; 285(4):34-41. PubMed ID: 11570040
    [No Abstract]   [Full Text] [Related]  

  • 54. Monoclonal antibody-conjugated immunotherapy of cancer.
    Imai K; Hareyama M; Makiguchi Y; Matsumoto H; Hinoda Y
    Int Rev Immunol; 1997; 14(2-3):213-27. PubMed ID: 9131388
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunotoxin therapy of lymphoma.
    Grossbard ML; Nadler LM
    Cancer Treat Res; 1993; 68():111-31. PubMed ID: 8105846
    [No Abstract]   [Full Text] [Related]  

  • 56. Targeted kill: from umbrellas to monoclonal antibodies.
    Byers VS; Baldwin RW
    J Clin Immunol; 1992 Nov; 12(6):391-405. PubMed ID: 1287032
    [No Abstract]   [Full Text] [Related]  

  • 57. Cytotoxic immune responses mediated by monoclonal antibodies in MS: incorrectly dismissed as ineffective?
    Killestein J; Polman CH
    Int MS J; 2007 Jun; 14(2):39-40. PubMed ID: 17686340
    [No Abstract]   [Full Text] [Related]  

  • 58. Advances in immunotoxin biology and therapy: a summary of the Fourth International Symposium on Immunotoxins.
    Frankel AE; FitzGerald D; Siegall C; Press OW
    Cancer Res; 1996 Feb; 56(4):926-32. PubMed ID: 8631036
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunoconjugates and immunotoxins for therapy of solid tumors.
    Hellström I; Trail P; Siegall C; Firestone R; Hellström KE
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S35-6. PubMed ID: 8765413
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunotoxin therapy for CNS tumor.
    Rustamzadeh E; Low WC; Vallera DA; Hall WA
    J Neurooncol; 2003; 64(1-2):101-16. PubMed ID: 12952291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.